Companies: 10,795·Total market cap: $144.5T
BioNeutra Global Corporation

BioNeutra Global Corporation

BGACFOTCConsumer Defensive● Active
$0.01
+$0.00(+0.00%)
Market Cap$260113
P/E Ratio
52W High$0.067
52W Low$0.0056

BioNeutra Global Corporation (BGACF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

bgacf · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for BioNeutra Global Corporation (BGACF) measures how much investors pay for each dollar of the company's trailing earnings. BGACF's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$0.05.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
EPS (TTM)
-$0.05
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioNeutra Global Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2004 – 2023 · Annual
PE Ratio (TTM)
5Y Avg 9.6x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 8 fiscal years · Front-end computed
Average
19.7x
8-yr mean
Median
4.5x
8-yr midpoint
Minimum
0.6x
Lowest year
Maximum
89.4x
Highest year
0.6x
Min
Q1 · 25%4.5x
Median
Q3 · 75%89.4x
Max
Historically Low

At N/A, BGACF's current P/E is lower than in 0% of its annual fiscal year readings over the past 8 years — historically low.

0th percentileHigher than 0 of 8 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Packaged Foods · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
BioNeutra Global Corporation
BioNeutra Global CorporationYou
BGACF
$0MN/A-$0.05
Accredited Solutions, Inc.
Accredited Solutions, Inc.
ASII
$0MN/A-$0.00
Latteno Food Corp.
Latteno Food Corp.
LATF
$0MN/A
Nabati Foods Global Inc.
Nabati Foods Global Inc.
MEALF
$0MN/A-$0.06
Bettermoo(d) Food Corporation
Bettermoo(d) Food Corporation
MOOOF
$0MN/A-$8.04
Pet Ecology Brands, Inc.
Pet Ecology Brands, Inc.
PECD
$0MN/A
Rogue Baron Plc
Rogue Baron Plc
SHNJF
$0MN/A-$0.04

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-0.05
2022-12-31
FY2022
$-0.06
2021-12-31
FY2021
$-0.06
2020-12-31
FY2020
$-0.08
2019-12-31
FY2019
$-0.27
2018-12-31
FY2018
2.10x$0.07
2017-12-31
FY2017
$-0.03
2016-12-31
FY2016
6.98x$0.02-80.7%
2015-12-31
FY2015
36.10x$0.00+6254.6%
2014-12-31
FY2014
0.57x$0.21-71.9%

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for BioNeutra Global Corporation (BGACF) measures how much investors pay for each dollar of the company's trailing earnings. BGACF's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$0.05.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.01 ÷ -$0.05 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BGACF pe ratio · 6 questions

BGACF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.01 and TTM EPS of -$0.05. Data sourced from Financial Modeling Prep via BGACF's SEC 10-K and 10-Q filings.

BGACF PE ratioWhat is BGACF PE ratioCurrent PE ratio of BGACFBGACF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioNeutra Global Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09